Pediatric oncology
View article: Pediatric Palliative Sedation: Ethical Considerations and Nursing Role in Pakistan
Pediatric Palliative Sedation: Ethical Considerations and Nursing Role in Pakistan Open
Pediatric palliative sedation (PPS) for refractory suffering at the end of life remains ethically complex and under-studied in low- and middle-income countries. This quantitative cross-sectional study aimed to explore nurses’ knowledge, at…
View article: Pediatric Palliative Sedation: Ethical Considerations and Nursing Role in Pakistan
Pediatric Palliative Sedation: Ethical Considerations and Nursing Role in Pakistan Open
Pediatric palliative sedation (PPS) for refractory suffering at the end of life remains ethically complex and under-studied in low- and middle-income countries. This quantitative cross-sectional study aimed to explore nurses’ knowledge, at…
View article: Protein nanoparticles: a promising frontier in reducing lung complications from chemotherapy in pediatric oncology
Protein nanoparticles: a promising frontier in reducing lung complications from chemotherapy in pediatric oncology Open
View article: Supplementary Data from Cardiometabolic Risk in Childhood Cancer Survivors: A Report from the Children's Oncology Group
Supplementary Data from Cardiometabolic Risk in Childhood Cancer Survivors: A Report from the Children's Oncology Group Open
Supplementary Data from Cardiometabolic Risk in Childhood Cancer Survivors: A Report from the Children's Oncology Group
View article: Supplementary Data from Cardiometabolic Risk in Childhood Cancer Survivors: A Report from the Children's Oncology Group
Supplementary Data from Cardiometabolic Risk in Childhood Cancer Survivors: A Report from the Children's Oncology Group Open
Supplementary Data from Cardiometabolic Risk in Childhood Cancer Survivors: A Report from the Children's Oncology Group
View article: Supplementary Data from Cardiometabolic Risk in Childhood Cancer Survivors: A Report from the Children's Oncology Group
Supplementary Data from Cardiometabolic Risk in Childhood Cancer Survivors: A Report from the Children's Oncology Group Open
Supplementary Data from Cardiometabolic Risk in Childhood Cancer Survivors: A Report from the Children's Oncology Group
View article: Supplementary Data from Cardiometabolic Risk in Childhood Cancer Survivors: A Report from the Children's Oncology Group
Supplementary Data from Cardiometabolic Risk in Childhood Cancer Survivors: A Report from the Children's Oncology Group Open
Supplementary Data from Cardiometabolic Risk in Childhood Cancer Survivors: A Report from the Children's Oncology Group
View article: Supplementary Data from Cardiometabolic Risk in Childhood Cancer Survivors: A Report from the Children's Oncology Group
Supplementary Data from Cardiometabolic Risk in Childhood Cancer Survivors: A Report from the Children's Oncology Group Open
Supplementary Data from Cardiometabolic Risk in Childhood Cancer Survivors: A Report from the Children's Oncology Group
View article: Targeted DNA Sequencing for Tailored Therapies in Children with Extracranial Solid Tumors
Targeted DNA Sequencing for Tailored Therapies in Children with Extracranial Solid Tumors Open
Next-generation sequencing (NGS) is instrumental for clinical decisions on molecularly targeted therapy (TT). In pediatric oncology, TT is a relatively rare choice administered chiefly on a tumor-agnostic basis. The investigation enrolled …
View article: Supplementary Data from Cardiometabolic Risk in Childhood Cancer Survivors: A Report from the Children's Oncology Group
Supplementary Data from Cardiometabolic Risk in Childhood Cancer Survivors: A Report from the Children's Oncology Group Open
Supplementary Data from Cardiometabolic Risk in Childhood Cancer Survivors: A Report from the Children's Oncology Group
View article: Supplementary Data from Cardiometabolic Risk in Childhood Cancer Survivors: A Report from the Children's Oncology Group
Supplementary Data from Cardiometabolic Risk in Childhood Cancer Survivors: A Report from the Children's Oncology Group Open
Supplementary Data from Cardiometabolic Risk in Childhood Cancer Survivors: A Report from the Children's Oncology Group
View article: Supplementary Data from Cardiometabolic Risk in Childhood Cancer Survivors: A Report from the Children's Oncology Group
Supplementary Data from Cardiometabolic Risk in Childhood Cancer Survivors: A Report from the Children's Oncology Group Open
Supplementary Data from Cardiometabolic Risk in Childhood Cancer Survivors: A Report from the Children's Oncology Group
View article: Data from Cardiometabolic Risk in Childhood Cancer Survivors: A Report from the Children's Oncology Group
Data from Cardiometabolic Risk in Childhood Cancer Survivors: A Report from the Children's Oncology Group Open
Background:Childhood cancer survivors are at risk for cardiovascular disease. We assessed the burden of potentially modifiable cardiometabolic risk factors (CRF) among survivors compared with population-matched controls.Methods:Survivors p…
View article: Considering inpatient antibiotic use at the end of life for children with cancer
Considering inpatient antibiotic use at the end of life for children with cancer Open
In adult oncology, high-quality end-of-life care (EOLC) metrics emphasize minimizing aggressive interventions. Although no guidelines specifically address antibiotic use at end-of-life (EOL), the Infectious Diseases Society of America clas…
View article: Supplementary Figure S1 from Impact of Genomic and Clinical Factors on Outcome of Children ≥18 Months of Age with Stage 3 Neuroblastoma with Unfavorable Histology and without <i>MYCN</i> Amplification: A Children's Oncology Group (COG) Report
Supplementary Figure S1 from Impact of Genomic and Clinical Factors on Outcome of Children ≥18 Months of Age with Stage 3 Neuroblastoma with Unfavorable Histology and without <i>MYCN</i> Amplification: A Children's Oncology Group (COG) Report Open
Supplemental Figure S1 Outcome by Chromosome 5 Status. (A) EFS and (B) OS by Chromosome 5 status
View article: Supplementary fig 2 from Impact of Genomic and Clinical Factors on Outcome of Children ≥18 Months of Age with Stage 3 Neuroblastoma with Unfavorable Histology and without <i>MYCN</i> Amplification: A Children's Oncology Group (COG) Report
Supplementary fig 2 from Impact of Genomic and Clinical Factors on Outcome of Children ≥18 Months of Age with Stage 3 Neuroblastoma with Unfavorable Histology and without <i>MYCN</i> Amplification: A Children's Oncology Group (COG) Report Open
Supplemental Figure S2 Outcome by Chromosome 9 Status. (A) EFS and (B) OS by Chromosome 9 status
View article: Nivel de Conocimientos sobre Cuidados Paliativos en Alumnos de Enfermeria en una Universidad Pública
Nivel de Conocimientos sobre Cuidados Paliativos en Alumnos de Enfermeria en una Universidad Pública Open
Los Cuidados Paliativos son esenciales en la atencion médica, ya que buscan aliviar el sufrimiento y mejorar lacalidad de vida de pacientes con enfermedades graves o terminales. Este estudio tuvo como objetivo evaluar los conocimientos sob…
View article: Peer Review Report For: Mapping Multisensory Journeys in Pediatric Oncology Care: Toward Emotionally Intelligent Healthcare Environments [version 1; peer review: 1 approved]
Peer Review Report For: Mapping Multisensory Journeys in Pediatric Oncology Care: Toward Emotionally Intelligent Healthcare Environments [version 1; peer review: 1 approved] Open
View article: From Caution to Readiness: The Case for Responsible AI in Pediatric Oncology Education
From Caution to Readiness: The Case for Responsible AI in Pediatric Oncology Education Open
View article: A Scoping Review of Pediatric Leukemia and Oral Health: Contemporary Approaches and Oncodental Insights
A Scoping Review of Pediatric Leukemia and Oral Health: Contemporary Approaches and Oncodental Insights Open
View article: Breaking the barrier: a guidelines-based review of antiangiogenesis drug resistance in pediatric cancer therapy
Breaking the barrier: a guidelines-based review of antiangiogenesis drug resistance in pediatric cancer therapy Open
The growth and metastatic potential of most solid and hematological tumors are angiogenesis-dependent. Antiangiogenic therapies have demonstrated clinical advantages in the treatment of numerous tumor types. Nevertheless, resistance to ant…
View article: PedROC 2.0: provider confidence in Wilms tumor management in sub-Saharan Africa: making the case for pediatric radiotherapy inclusion during basic medical training
PedROC 2.0: provider confidence in Wilms tumor management in sub-Saharan Africa: making the case for pediatric radiotherapy inclusion during basic medical training Open
Pediatric radiotherapy inclusion in basic medical training was significantly associated with higher provider confidence levels in managing Wilms tumor. These findings support the potential for integrated pediatric radiotherapy training int…
View article: Clinical validation of the Hilab lens for AI supported point of care CBC testing in pediatric oncology
Clinical validation of the Hilab lens for AI supported point of care CBC testing in pediatric oncology Open
These results support the Hilab Lens as a reliable and accessible alternative to conventional hematology analyzers. Its ease of use and rapid turnaround make it suitable for environments where timely CBC testing is essential. The high acce…
View article: Impact of TauroLock™-HEP500 versus unfractionated heparin for prevention of catheter complications in children with malignancy: a prospective, randomized, controlled study
Impact of TauroLock™-HEP500 versus unfractionated heparin for prevention of catheter complications in children with malignancy: a prospective, randomized, controlled study Open
Background and aims Central venous catheters (CVCs) are essential for drug delivery in pediatric oncology patients but are associated with complications such as infection and thrombosis. This study aimed to compare the effects of taurolidi…
View article: The effect of neighborhood deprivation on access to surgical care for pediatric renal tumors
The effect of neighborhood deprivation on access to surgical care for pediatric renal tumors Open
Objectives Early identification of pediatric renal tumors improves outcomes. Neighborhood deprivation, a composite measure of social determinants of health, is associated with poor oncological outcomes. We studied whether neighborhood depr…
View article: Toward Better Conversations: Assessing Caregiver–Child Communication in Pediatric Oncology
Toward Better Conversations: Assessing Caregiver–Child Communication in Pediatric Oncology Open
Purpose Effective parent–child communication is central to coping with the psychosocial challenges of pediatric cancer, yet few studies have examined how caregivers and children perceive their communication. This study investigated congrue…
View article: Enhancing Quality of Life and Reducing Anxiety in Children with Leukemia Through Social Support: A Pilot Cross-sectional Study
Enhancing Quality of Life and Reducing Anxiety in Children with Leukemia Through Social Support: A Pilot Cross-sectional Study Open
Approximately 400,000 new cases of cancer are diagnosed annually among children and adolescents. Leukemia, the most prevalent pediatric cancer, is a leading cause of mortality in children under 15 years of age. Despite advances in treatmen…
View article: Genomic Profiling of Pediatric Solid Tumors With a Dual <scp>DNA</scp> / <scp>RNA</scp> Panel: <scp>JCCG‐TOP2</scp> Study
Genomic Profiling of Pediatric Solid Tumors With a Dual <span>DNA</span> / <span>RNA</span> Panel: <span>JCCG‐TOP2</span> Study Open
To develop an optimized genomic medicine platform for pediatric cancers, a nationwide cancer genome profiling project was conducted from January 2022 to February 2023 in collaboration with the Japan Children's Cancer Group. This prospectiv…
View article: Formative Development of the Smart Pediatric Oncology Tracker of Symptoms (SPOTS): A Web-based Interface for the Pediatric PRO-CTCAE (Preprint)
Formative Development of the Smart Pediatric Oncology Tracker of Symptoms (SPOTS): A Web-based Interface for the Pediatric PRO-CTCAE (Preprint) Open
BACKGROUND Children undergoing cancer treatment experience a range of treatment-related toxicities that significantly affect quality of life and adherence to therapy. Current methods for symptom reporting rely heavily on clinician interpr…
View article: The impact of focused federal initiatives on pediatric cancer research
The impact of focused federal initiatives on pediatric cancer research Open
Federal initiatives, including the Childhood Cancer Data Initiative and the Childhood Cancer Survivorship, Treatment, Access, and Research Act, are advancing pediatric cancer data sharing and strengthening infrastructure required for clini…